OXTRIPHYLLINE PEDIATRIC Drug Patent Profile
Which patents cover Oxtriphylline Pediatric, and when can generic versions of Oxtriphylline Pediatric launch?
Oxtriphylline Pediatric is a drug marketed by Morton Grove and is included in one NDA.
The generic ingredient in OXTRIPHYLLINE PEDIATRIC is oxtriphylline. There is one drug master file entry for this compound. Additional details are available on the oxtriphylline profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXTRIPHYLLINE PEDIATRIC?
- What are the global sales for OXTRIPHYLLINE PEDIATRIC?
- What is Average Wholesale Price for OXTRIPHYLLINE PEDIATRIC?
Summary for OXTRIPHYLLINE PEDIATRIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 1,720 |
| DailyMed Link: | OXTRIPHYLLINE PEDIATRIC at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE PEDIATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
